RecruitingNCT07154186

Triglycerides Glucose Index on Angiographic Profiling of Non-Diabetic Premature Coronary Artery Disease Patients

Impact of Triglycerides Glucose Index on Angiographic Profiling of Non-Diabetic Premature Coronary Artery Disease Patients

Sponsor

Sohag University

Enrollment

180 participants

Start Date

Sep 4, 2025

Study Type

OBSERVATIONAL

Conditions

Coronary Artery Disease Non-Diabetic Premature Triglycerides Glucose Index Angiographic Profiling

Summary

This study aims to evaluate the impact of the triglyceride-glucose (TyG) index on the angiographic profiling of non-diabetic patients with premature coronary artery disease (CAD).

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Coronary Angiographic Assessment for people with angiographic profiling, coronary artery disease, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERCoronary Angiographic Assessment

Coronary angiographic assessment will be performed for all patients.

Locations(1)

Sohag University

Sohag, Egypt

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07154186

Related Trials

A Phase 2b Clinical Trial of YN001 in Adults With Coronary Atherosclerosis

NCT07521007

Pivotal Study of the SUpira System in Patients Undergoing High-Risk Percutaneous COronaRy InTervention (HRPCI)

NCT0729674419 locations